Welcome to Supply Chain Solutions!
On behalf of Pharmaceutical Commerce, welcome to Supply Chain Solutions, a new monthly newsletter!
Supply Chain Solutions is intended to provide fresh content based on sustaining the flow of products, information, and funds. This will be delivered via the latest news items, video content, and podcast episodes. Be sure to stay in the loop by subscribing and following, and without further ado, we present to you... volume I!
US News Ranks Its Top Medicare Advantage and Part D Companies
Approximately 1.5 million American seniors could lose their Medicare Advantage plans, while another 3.5 million will lose their Part D drug plans by 2025. Given its relevancy, U.S. News & World Report , a media company specializing in healthcare rankings and consumer advice, unveiled its top Medicare Advantage and Medicare Part D companies, based on their national performance among various consumer-value award categories.
When it came down to the 2025 national Medicare Advantage and Part D company winners, US News computed insurers' ratings for three Medicare Advantage award categories: Screening & Prevention, Care Continuity and Highest Satisfaction, and one specific Medicare Part D award category: Highest Satisfaction.
Telemedicine Perspectives from Cancer Patients
Pre-pandemic, when it came to cancer care, telemedicine was used in less than 1% of all Medicare outpatient meetings, often being used in very specific situations such as for genetic counseling, care in rural communities, and for survivorship. Comparing that to COVID era, particularly Q2 2020, 47% of all Medicare users had at least one telemedicine service, while this amount was only 7% in Q1 2020.
Being that satisfaction since the early stages of the COVID-19 pandemic remains essentially unexplored at this point, a survey study published in JAMA Network Open sought to determine if in fact cancer patients are satisfied with telemedicine.
Recommended by LinkedIn
Cryoport Opens New CoE in Europe
Cryoport Inc. , a temperature-controlled supply chain solution provider for the life sciences industry, has opened its newest IntegriCell facility in Villers-le-Bouillet, Liege, Belgium.
IntegriCell is the company’s branded standardized bioprocessing, cryopreservation, and distribution solution for the cell therapy market. The solution is designed to enhance cell therapy manufacturing efficiency and flexibility, while providing safety, quality and product stability for these treatments in the process.
Video: Properly Preparing for Supply Chain Disruptions
In a video interview with Pharma Commerce, Gaurav Gupta , managing director and head of R&D at Kotter, discusses the regulatory pressures and rising R&D costs impacting the pharmaceutical industry as it looks toward 2025. Gupta highlighted that many regulatory challenges, such as drug pricing pressures from the Inflation Reduction Act, will persist in the coming years. Additionally, he pointed out the growing integration of real-world evidence into clinical trials and the need for regulators to keep pace with emerging technologies like AI. Gupta believes that these trends will continue to shape the industry without major new disruptions expected in the short term.
He also comments on the steps pharmaceutical leaders should take to better prepare their teams and organizations for supply chain disruptions; specific technical and "soft" skills that will be critical for pharmaceutical leaders and frontline employees to thrive in the evolving industry landscape, and how this can help when it comes to proactivity in handling talent shortages.